Inhibition of the motility of melanoma cells using interference RNA against CD9;Inhibición de la motilidad de células de melanoma con ARN de interferencia de CD9

Actas Dermo-Sifiliograficas

Volumn 96, Issue 1, 2005, Pages 30-36

  Peñas, Pablo F ^a   García López, María A ^a   Del Río, Olga Barreiro ^a  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

CD151; CD9; Interference RNA; Melanoma; Migration; Motility; Tetraspanins

Indexed keywords

CD151 ANTIGEN; CD81 ANTIGEN; CD9 ANTIGEN; FLUORESCEIN ISOTHIOCYANATE; MONOCLONAL ANTIBODY; PROTEIN; RNA; TETRASPANIN; UNCLASSIFIED DRUG;

ARTICLE; CELL MOTILITY; CELL SELECTION; FLOW CYTOMETRY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MELANOMA CELL; WOUND HEALING;

EID: 15944392072     PISSN: 00017310     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0001-7310(05)73029-5     Document Type: Article

References (16)

1. Plasterk RH. RNA silencing: the genome's immune system. Science 2002;296:1263-5.
2. Scherr M, Morgan MA, Eder M. Gene silencing mediated by small interfering RNAs in mammalian cells. Curr Med Chem 2003;10:245-56.
3. Hannon GJ. RNA interference. Nature 2002;418:244-51.
4. Elbashir S, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in mammalian ceell culture. Nature 2001; 411:494-8.
5. Miyake M, Koyama M, Seno M, Ikeyama S. Identification of the motility-related protein (MRP-1), recognized by monoclonal antibody M31-15, which inhibits cell motility. J Exp Med 1991;174:1347-54.
6. Yáñez-Mo M, Tejedor R, Rousselle P, Sánchez-Madrid F. Tetraspanins in intercellular adhesion of polarized epithelial cells: spatial and functional relationship to integrins and cadherins. J Cell Sci 2001;114:577-87.
7. Tarrant JM, Robb L, Van Spriel AB, Wright MD. Tetraspanins: molecular organisers of the leukocyte surface. Trends Immunol 2003;24:610-7.
8. Berditchevski F. Complexes of tetraspanins with integrins: more than meets the eye. J Cell Sci 2001;114:4143-51.
9. Longo N, Yáñez-Mo M, Mittelbrunn M, De la Rosa G, Muñoz ML, Sánchez-Madrid F, et al. Regulatory role of tetraspanin CD9 in tumor-endothelial cell interaction during transendothelial invasion of melanoma cells. Blood 2001;98:37l7-26.
10. Arroyo AG, Sánchez-Mateos P, Campanero MR, Martín-Padura I, Dejana E, Sánchez-Madrid F. Regulation of the VLA integrin-ligand interactions through β1 subunit. J Cell Biol 1992;117:659-70.
11. Peñas PF, Gómez M, Buezo GF, Rios L, Yáñez-Mo M, Cabañas C, et al. Differential expression of activation epitopes of beta1 integrins in psoriasis and normal skin. J Invest Dermatol 1998;111:19-24.
12. Yáñez-Mo M, Alfranca A, Cabañas C, Marazuela M, Tejedor R, Ursa MA, et al. Regulation of endothelial cell motility by complexes of tetraspan molecules CD81/TAPA-1 and CD151/PETA-3 with alpha3 beta1 integrin localized at endothelial lateral junctions. J Cell Biol 1998;141:791-804.
13. De Haas M, Von dem Borne AEGK. Platelet antigens: Section report. En: Kishimoto T, Kikutani H, Von dem Borne AEGK, et al, editores. Leucocyte typing VI: White cell differentiation antigens. New York: Garland Publishing 1997; p. 625-8.
14. Peñas PF, García-Díez A, Sánchez-Madrid F, Yáñez-Mo M. Tetraspanins are localized at motility-related structures and involved in normal human keratinocyte wound healing migration. J Invest Dermatol 2000;114:1126-35.
15. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998;391:806-11.
16. Ikeyama S, Koyama M, Yamaoko M, Sasada R, Miyake M. Suppression of cell motility and metastasis by transfection with human motility-related protein (MRP-1/CD9) DNA. J Exp Med 1993;177:1231-7.